Benzphetamine
| Benzphetamine | |
|---|---|
| Salts [] | |
|---|---|
| Benzphetamine hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 239.35 g/mol [1] |
| Appearance | Liquid [1] |
| Melting point | 129-130 [1] |
| Boiling point | 127 °C at 0.02 mm Hg [1] |
| Decomposition | When heated to decomposition it emits very toxic fumes of /hydrogen chloride and nitrogen oxides/. /Benzphetamine hydrochloride/ [1] |
| Solubility | Readily soluble [1] |
| Predicted LogP | 4.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H21N |
| IUPAC name | (2S)-N-benzyl-N-methyl-1-phenylpropan-2-amine |
| SMILES | C[C@@H](CC1=CC=CC=C1)N(C)CC2=CC=CC=C2 |
| InChI | InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1 |
| InChIKey | YXKTVDFXDRQTKV-HNNXBMFYSA-N |
| CAS number | 156-08-1 |
| UNII | 0M3S43XK27 |
| PubChem CID | 5311017 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 4–6 hours |
| Routes of administration | By mouth |
| Dependence liability | High[3] |
| Toxicity [] | |
|---|---|
| LD50 | Rat: - Oral: 160 mg/kg [1] |
Benzphetamine (also known as (+)-benzphetamine, (S)-benzphetamine, Benzfetamina, benzaphetamine, Benzfetaminum, (S)-(+)-benzphetamine, N-Benzylmethamphetamin, D-N-Methyl-N-benzyl-β-phenylisopropylamine, (αS)-N,α-dimethylphenethylamine or (+)-N-benzyl-N,α-dimethylphenethylamine) is a prodrug and stimulant substance of the amphetamine and n-benzylphenethylamine class.
Chemistry
Salts []
Stereochemistry []
Benzphetamine is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Benzphetamine matches Lipinski's rule of five.Reagents
There are currently 5 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | red > brown | |
| Mecke | green > yellow | |
| Mandelin | brilliant yellow green | |
| Liebermann | yellow > brown | |
| Froehde | yellow > orange |
Pharmacology
MeSH Classification
- central nervous system stimulants (M0001063)
- sympathomimetics (M0020947)
- dopamine agents (M0023499)
- adrenergic agents (M0027961)
- adrenergic uptake inhibitors (M0028095)
- dopamine uptake inhibitors (M0028098)
Mechanism of action []
The mechanism of action of these drugs is not fully understood, however it may be similar to that of amphetamines. Amphetamines stimulate noepinephrine and dopamine release in nerve endings in the lateral hypothalamic feeding centre, decreasing appetite. This release is mediated by the binding of benzphetamine to centrally located adrenergic receptors. [1]
Metabolism
Benzphetamine acts as a prodrug for:
| Metabolic pathways [] |
|---|
Interactions []
Medical side effects []
19 side effects listed on drug labels in SIDER 4.1 (benzphetamine).
- Decreased appetite
- Diarrhoea
- Dizziness
- Headache
- Cardiac valve disease
- Hypersensitivity
- Nausea
- Palpitations
- Hyperhidrosis
- Tachycardia
- Tremor
- Urticaria
- Allergic urticaria
- Agitation
- Dyspepsia
- Gastrointestinal disorder
- Psychotic disorder
- Cardiomyopathy
- Insomnia
Indications
- Obesity
Subjective effects []
Legal status []
- Australia: Benzphetamine is a Schedule 4.
- Brazil: Benzphetamine is a F2.[4]
- Canada: Benzphetamine is a Schedule I.
- Germany: Benzphetamine is a Anlage I under the "Betäubungsmittelgesetz (BtMG)".
- United States: Benzphetamine is a Schedule III under the "Controlled Substances Act".
- United Kingdom: Benzphetamine is a Class C under the "Misuse of Drugs Act 1971".
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5311017, Benzphetamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5311017
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Benzphetamine. UNII: 0M3S43XK27. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/0M3S43XK27
Benzphetamine. Toxnet. https://www.nlm.nih.gov/toxnet/index.html
RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 05:06:26 |
| drugspro | ok | 2026-11-20 05:06:22 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 05:06:22 |
| gsrs | ok | 2026-11-20 05:06:24 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015003) | 2026-11-20 05:06:22 |
| kegg | ok | 2026-11-20 05:06:23 |
| pubchem | ok | 2026-11-20 05:06:21 |
| missing (no r/tripreports posts mention it) | 2026-11-20 05:06:22 | |
| sider | ok | 2026-11-20 05:06:22 |
| structure | ok | 2026-11-20 05:06:22 |
| wikipedia | ok | 2026-11-20 05:06:22 |